Health Care Select Sector SPDR Fund
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
23% more first-time investments, than exits
New positions opened: 215 | Existing positions closed: 175
0% more funds holding
Funds holding: 1,716 [Q3] → 1,723 (+7) [Q4]
6% less repeat investments, than reductions
Existing positions increased: 611 | Existing positions reduced: 650
1.83% less ownership
Funds ownership: 73.27% [Q3] → 71.43% (-1.83%) [Q4]
8% less capital invested
Capital invested by funds: $30.6B [Q3] → $28.3B (-$2.3B) [Q4]
27% less call options, than puts
Call options by funds: $1.92B | Put options by funds: $2.62B
27% less funds holding in top 10
Funds holding in top 10: 112 [Q3] → 82 (-30) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for XLV.
Financial journalist opinion
Based on 14 articles about XLV published over the past 30 days
Negative
Bloomberg Markets and Finance
3 days ago
Trump Says Pharmaceutical Tariffs Coming in Near Future
President Donald Trump said tariffs on pharmaceuticals will be coming in the “not too distant future” and fit in the category of tariffs imposed on cars, steel, and aluminum. Trump spoke with reporters Monday in the Oval Office.
Negative
Zacks Investment Research
1 week ago
5 Sector ETFs Set for Q1 Earnings Growth Amid Tariff Woes
We highlight ETFs from the sectors expected to post Q1 earnings growth that could make great plays amid tariff woes.
Negative
CNBC
1 week ago
Trump's pharmaceutical tariffs could raise costs for patients, worsen drug shortages
President Donald Trump's planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences on the drug supply chain, manufacturers and American patients, some experts told CNBC. The tariffs could disrupt the complex pharmaceutical supply chain, potentially driving up the prices of drugs in the U.S. and exacerbating shortages of critical medicine.
Neutral
Zacks Investment Research
1 week ago
Should You Invest in the Health Care Select Sector SPDR ETF (XLV)?
Designed to provide broad exposure to the Healthcare - Broad segment of the equity market, the Health Care Select Sector SPDR ETF (XLV) is a passively managed exchange traded fund launched on 12/16/1998.
Negative
Reuters
1 week ago
Explainer: Prescription drugs become a target in Trump's trade war
U.S. President Donald Trump late on Tuesday reiterated he would impose tariffs on imports of pharmaceutical products that have long been spared from past trade disputes due to the potential for harm to patients.
Negative
CNBC
1 week ago
Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly'
Trump doubled down on plans to soon impose "major" pharmaceutical tariffs, while early stage startups dominated digital health funding deals in first quarter.
Negative
Barrons
1 week ago
Healthcare Stocks Aren't a Shelter From the Tariff Storm
It's increasingly clear that broad bets on healthcare don't make sense as a refuge from the market chaos.
Negative
Market Watch
1 week ago
Why drug stocks are no longer a safe haven from the stock market's turmoil
Shares of drugmakers were taking a broad beating Wednesday, after President Donald Trump indicated that pharmaceuticals will no longer be excluded from tariffs.
Negative
CNBC Television
1 week ago
Mizuho's Jared Holz: Here's why healthcare stocks are under pressure
Jared Holz, Mizuho Securities America healthcare sector strategist, joins CNBC's 'Power Lunch' to discuss whether the healthcare sector is actually a safe haven during the market turmoil, why healthcare companies aren't getting more investor respect despite their percentage of national output, and more.
Positive
Zacks Investment Research
1 week ago
5 ETF Picks for April
Bet on defensive and high-earnings growth sectors in this tumultuous April.
Charts implemented using Lightweight Charts™